26 Jan 2010 - Nacalai USA will sell Trilink Biotechnologies' modified nucleic acid products in Japan, Singapore, South Korea and Taiwan, as a result of the companies signing a distribution agreement.
The agreement will provide researchers in the Asian market access to high quality, modified nucleic acid products to further advance research efforts in areas such as molecular biology and proteomics.
